Clots are AstraZeneca’s latest curse

Hailed as a cheap, easy to store not-for-profit vaccine, the AstraZeneca shot has suffered a litany of setbacks.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

The information on this site is of a general nature only and is not intended to address the specific circumstances of any particular individual or entity. It is not intended or implied to be a substitute for professional advice. Read more.